Litcius/Paper detail

Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer

Albina Stocker, Andreas Trojan, Constanze Elfgen, Marie-Louis Hilbers, Linda Moskovszky, Zsuzsanna Varga

2020Breast Cancer Research and Treatment13 citationsDOI

Topics & Concepts

ImmunohistochemistryBreast cancerFluorescence in situ hybridizationOncologyMedicineInternal medicineCancerConcordanceMetastatic breast cancerPathologyBiologyGeneBiochemistryChromosomeHER2/EGFR in Cancer ResearchBreast Cancer Treatment StudiesAdvanced Breast Cancer Therapies
Differential prognostic value of positive HER2 status determined by immunohistochemistry or fluorescence in situ hybridization in breast cancer | Litcius